Moreover, measuring CA125 in tumor tissue, among late-stage ovarian cancer patients a reduction of hazard ratio (HR = 0.63) has been observed when tumor tissue displayed positive CA125 expression; a positive correlation was found between elevated serum CA125 levels and elevated levels of CA125 tissue expression [14]. The gene discussed is MUC16; the disease is ovarian carcinoma.